Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 12/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 12/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 12/20 | 0.51 |
| ▸ | FPR2 | P25090 | 1/20 | 0.48 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7705768 | 1.00 | SLC6A2 (0.51) | SLC6A2SLC6A4SLC6A3FPR2PROKR1 | |
| SCHEMBL6907975 | 1.00 | SLC6A2 (0.51) | SLC6A2SLC6A4SLC6A3FPR2PROKR1 | |
| SCHEMBL16321856 | 0.88 | SLC6A2 (0.68) | SLC6A2SLC6A4SLC6A3FPR2PROKR1 | |
| Hydrochloric Acid SCHEMBL15535996 | 0.86 | SLC6A2 (0.71) | SLC6A2SLC6A4SLC6A3FPR2PROKR1 | |
| SCHEMBL9542135 | 0.85 | SLC6A2 (0.45) | SLC6A2SLC6A4SLC6A3FPR2PROKR1 | |
| SCHEMBL9642466 | 0.82 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3FPR2PROKR1 | |
| SCHEMBL23536155 | 0.80 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3FPR2PROKR1 | |
| SCHEMBL16979039 | 0.80 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3FPR2PROKR1 | |
| SCHEMBL17609123 | 0.80 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3FPR2PROKR1 | |
| SCHEMBL9643779 | 0.80 | SLC6A4 (0.47) | SLC6A2SLC6A4SLC6A3FFAR1P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6770463-B2 | INSECTICIDES AND ACARICIDES; AROMATIC SUBSTITUTED HALOALKENES | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-03 | — | — | US | disclosed |
| EP-1307418-A2 | PROCESS FOR THE PREPARATION OF CHIRAL 1,4-DIARYL-2-FLUORO-2-BUTENES | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-07 | — | — | EP | disclosed |
| US-20020032351-A1 | Process for the preparation of chiral isofluoroenes | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-14 | — | — | US | disclosed |
| WO-2002012155-A2 | PROCESS FOR THE PREPARATION OF CHIRAL 1,4-DIARYL-2-FLUORO-2-BUTENES | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032351-A1 | Process for the preparation of chiral isofluoroenes | CYP51A1, CYP4F11, CYP2F1 | SLC6A2 4538/4885SLC6A4 4522/4885SLC6A3 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.